Question 1

What is the catalog number for Pyrazine-2-carboxylic acid?

Accepted Answer

The catalog number for Pyrazine-2-carboxylic acid is 286593.

Question 2

What sizes are available for Pyrazine-2-carboxylic acid?

Accepted Answer

Pyrazine-2-carboxylic acid is available in the following size(s): 25 g, 50 g, 100 g, 250 g, 500 g.

Question 3

How many pack sizes does Pyrazine-2-carboxylic acid come in?

Accepted Answer

Pyrazine-2-carboxylic acid is available in 5 different pack sizes.

Question 4

Is Pyrazine-2-carboxylic acid in stock?

Accepted Answer

Pyrazine-2-carboxylic acid is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 6

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 7

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Pyrazine-2-carboxylic acid

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

SNAP25 (NM_130811) Human Recombinant Protein

DLX4 (NM_001934) Human Over-expression Lysate

2-(4,5-Dihydro-1h-imidazol-2-yl)pyridine

PON2 (N-term) Rabbit Polyclonal Antibody

Human C6orf204 (CEP85L) activation kit by CRISPRa

Gemin 8 (GEMIN8) Human Gene Knockout Kit (CRISPR)